subscribeSubscribe
Madrigal Pharmaceuticals launches Rezdiffra in the US

Madrigal Pharmaceuticals launches Rezdiffra in the US
GLOBENEWSWIRE
09 Apr 2024
Share Share
Docs sing praises of Madrigal`s Rezdiffra, predict rapid uptake

Docs sing praises of Madrigal`s Rezdiffra, predict rapid uptake
Nick Paul Taylor FIERCE PHARMA
08 Apr 2024
Share Share
Amber Pharmacy Selected to Dispense Rezdiffra™ to Treat NASH

Amber Pharmacy Selected to Dispense Rezdiffra™ to Treat NASH
BUSINESSWIRE
25 Mar 2024
Share Share
After MASH nod, Madrigal plots $600M stock sale to support launch

After MASH nod, Madrigal plots $600M stock sale to support launch
Zoey Becker FIERCE PHARMA
19 Mar 2024
Share Share
Galmed Announces Grant of Patent for Combination of Aramchol with Resmetirom

Galmed Announces Grant of Patent for Combination of Aramchol with Resmetirom
PR NEWSWIRE
15 Mar 2024
Share Share
FDA approves Madrigal drug as first treatment for common NASH liver disease

FDA approves Madrigal drug as first treatment for common NASH liver disease
CNBC
15 Mar 2024
Share Share
Madrigal Pharmaceuticals Announces EMA Validation of its MAA for Resmetirom

Madrigal Pharmaceuticals Announces EMA Validation of its MAA for Resmetirom
GLOBENEWSWIRE
05 Mar 2024
Share Share
Madrigal says new data show resmetirom has `broad` effects in NASH

Madrigal says new data show resmetirom has `broad` effects in NASH
GLOBENEWSWIRE
11 Nov 2023
Share Share
FDA gives Madrigal`s NASH drug priority review, no AdComm

FDA gives Madrigal`s NASH drug priority review, no AdComm
Gabrielle Masson FIERCE BIOTECH
14 Sep 2023
Share Share
Madrigal Announces NDA Acceptance and Priority Review of NDA for Resmetirom

Madrigal Announces NDA Acceptance and Priority Review of NDA for Resmetirom
PRESS RELEASE
13 Sep 2023
Share Share